The White House says President Trump’s deals with drugmakers could save the US economy $529 billion over 10 years by bringing prescription prices down toward levels seen in other developed countries. The effort is set to be a major talking point ahead of midterm elections, even as Democrats question whether the projected savings will hold up.
India is increasing petrochemical feedstock supplies to pharmaceutical manufacturers to protect essential medicine availability amid West Asia supply-chain disruptions. Refiners are now pushing key inputs such as propylene, ammonia and methanol, while customs duties have been reduced to lower landed costs. As a result, domestic drug prices are holding steady.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
A war-linked pharma cost shock is now rippling into India’s healthcare market. Vizag chemists say paracetamol and other essential generics may see hikes of 30–40% as manufacturers face surging raw material prices, especially from West Asia. Current supplies are said to be stable, but future revisions could raise retail bills. The government is working to curb volatility and maintain availability.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
